Details for New Drug Application (NDA): 077651
✉ Email this page to a colleague
The generic ingredient in ZONISAMIDE is zonisamide. There are nineteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the zonisamide profile page.
Summary for 077651
| Tradename: | ZONISAMIDE |
| Applicant: | Glenmark Pharms Inc |
| Ingredient: | zonisamide |
| Patents: | 0 |
Pharmacology for NDA: 077651
| Mechanism of Action | Carbonic Anhydrase Inhibitors P-Glycoprotein Inhibitors |
| Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 077651
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651 | ANDA | Proficient Rx LP | 63187-583 | 63187-583-30 | 30 CAPSULE in 1 BOTTLE (63187-583-30) |
| ZONISAMIDE | zonisamide | CAPSULE;ORAL | 077651 | ANDA | Proficient Rx LP | 63187-583 | 63187-583-60 | 60 CAPSULE in 1 BOTTLE (63187-583-60) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 25MG | ||||
| Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
| Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No | ||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
| Approval Date: | Jan 30, 2006 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
